Acta Chir Orthop Traumatol Cech. 2024; 91(1):52-56 | DOI: 10.55095/achot2024/003

Two-Stage Treatment Protocol of Fungal Periprosthetic Hip and Knee Joint Infections: the Clinical Experience from a Single Center ExperienceOriginal papers

J. XU1, W. SUN2, Y. WANG2, H. JIANG2, H. DING2, Q. CHENG2, N. BAO2, J. MENG2
1 Department of Orthopaedics, Changzhou Traditional Chinese medical hospital, affiliated to Nanjing University of Traditional Chinese Medicine, Changzhou, Jiangsu Province, China
2 Department of Orthopaedics, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu Province, China

Purpose of the study To evaluate the clinical results and safety of fungal periprosthetic joint Infections (fPJIs) using two-stage treatment protocol. Material and methods 8 patients with fPJIs (3 hips and 5 knees) using two-stage revision were reviewed retrospectively and followed up at least 2 years. The preoperative demographic data, two-stage treatment protocol, results of microbiology and histologic workup and postoperative follow-up results (reimplantation success rate and infection free time) were recorded. Results 7 patients got successful reimplantation, with a 75% reimplantation success rate. Two patients got knee arthrodesis eventually. All patients were infection free with a median follow-up of 4.0 ± 2.0 years (range, 2-7 years). Of them, Candida species were found in 7 patients, while non-Candida specimen was only isolated in 1 patient with Aspergillus. Only 2 patients had coexisting bacterial infection (Methicillin-resistant coagulase-negative Staphylococci and Proteus mirabilis respectively). The average interval between the initial surgery and diagnosis of fPJIs was 21.50±34.79 months (range, 4-104 months). The mean time of spacer implantation was 7.75±2.77 months (range, 6-14 months). None serious complication or above knee amputation was found. Discussion fPJIs are very rare and considerable challenge after total hip or knee arthroplasty. The goal of therapy is to eradicate local infection and maintain function. Candida species were the most common pathogen. The duration between spacer placement and staged reimplantation was highly variable, and generally dependent upon the results of joint aspirates and inflammatory markers. The current study shows that the two-stage treatment protocol is recommended for fungal periprosthetic hip and knee joint infections. Conclusions The two-stage treatment protocol is recommended for fungal periprosthetic hip and knee joint infections. The safety and efficacy of biantibiotical impregnated (antifungal + antibiotics) cement spacer is confirmed. Further evidence-based work is needed to determine the optimal drug dose and reimplantation time.

Keywords: two-stage treatment protocol, fungal periprosthetic infections, hip spacer, knee spacer.

Accepted: March 5, 2024; Published: February 1, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
XU J, SUN W, WANG Y, JIANG H, DING H, CHENG Q, et al.. Two-Stage Treatment Protocol of Fungal Periprosthetic Hip and Knee Joint Infections: the Clinical Experience from a Single Center Experience. Acta Chir Orthop Traumatol Cech. 2024;91(1):52-56. doi: 10.55095/achot2024/003. PubMed PMID: 38447565.
Download citation

References

  1. Azzam K, Parvizi J, Jungkind D, Hanssen A, Fehring T, Springer B, Bozic K, Della Valle C, Pulido L, Barrack R. Microbiological, clinical, and surgical features of fungal prosthetic joint infections: a multi-institutional experience. J Bone Joint Surg Am. 2009;91(Suppl 6):142-149. Go to original source... Go to PubMed...
  2. Bedini A, Venturelli C, Mussini C, Guaraldi G, Codeluppi M, Borghi V, Rumpianesi F, Barchiesi F, Esposito R. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. Clin Microbiol Infect. 2006;12:75-80. Go to original source... Go to PubMed...
  3. Belden K, Cao L, Chen J, Deng T, Fu J, Guan H, Jia C, Kong X, Kuo FC, Li R, Repetto I, Riccio G, Tarabichi M. Hip and knee section, fungal periprosthetic joint infection, diagnosis and treatment: proceedings of international consensus on orthopedic infections. J Arthroplasty. 2019;34(2S):387-391. Go to original source... Go to PubMed...
  4. Brown TS, Petis SM, Osmon DR, Mabry TM, Berry DJ, Hanssen AD, Abdel MP. Periprosthetic joint infection with fungal pathogens. J Arthroplasty. 2018;33:2605-2612. Go to original source... Go to PubMed...
  5. Chaffin WL, López-Ribot JL, Casanova M, Gozalbo D, Martínez JP. Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol Mol Biol Rev. 1998;62:130-180. Go to original source... Go to PubMed...
  6. Coad BR, Kidd SE, Ellis DH, Griesser HJ. Biomaterials surfaces capable of resisting fungal attachment and biofilm formation. Biotechnol Adv. 2014;32:296-307. Go to original source... Go to PubMed...
  7. Cunningham B, McLaren AC, Pauken C, Mclemore R. Liposomal formulation increases local delivery of amphotericin from bone cement: a pilot study. Clin Orthop Relat Res. 2012;470:2671-2676. Go to original source... Go to PubMed...
  8. Diaz-Ledezma C, Higuera CA, Parvizi J. Success after treatment of periprosthetic joint infection: a Delphi-based international multidisciplinary consensus. Clin Orthop Relat Res. 2013;471:2374-2382. Go to original source... Go to PubMed...
  9. Escolà-Vergé L, Rodríguez-Pardo D, Lora-Tamayo J, Morata L, Murillo O, Vilchez H, Sorli L, Carrión LG, Barbero JM, Palomino-Nicás J, Bahamonde A, Jover-Sáenz A, Benito N, Escudero R, Sampedro MF, Vidal RP, Gómez L, Corona PS, Almirante B, Ariza J, Pigrau C; Study Group on Osteoarticular Infections of the Spanish Society of Clinical Microbiology and Infectious Diseases (GEIO-SEIMC), and the Spanish Network for Research in Infectious Pathology (REIPI). Candida periprosthetic joint infection: a rare and difficult-to-treat infection. J Infect. 2018;77:151-157. Go to original source... Go to PubMed...
  10. Goff T, Rambani R, Ng AB. Current concepts in the management of periprosthetic fungal joint infection using antifungal bone cement. Curr Orthop Pract. 2014;25:169-174. Go to original source...
  11. Grimsrud C, Raven R, Fothergill AW, Kim HT. The in vitro elution characteristics of antifungal-loaded PMMA bone cement and calcium sulfate bone substitute. Orthopedics. 2011;34:378-381. Go to original source... Go to PubMed...
  12. Gross CE, Della Valle CJ, Rex JC, Traven SA, Durante EC. Fungal periprosthetic joint infection: a review of demographics and management. J Arthroplasty. 2021;36:1758-1764. Go to original source... Go to PubMed...
  13. Hanusrichter Y, Frieler S, Gessmann J, Schulte M, Krejczy M, Schildhauer T, Baecker H. Does the implementation of the PRO-IMPLANT Foundation treatment algorithm improve the outcome of chronic periprosthetic knee infections? Mid-term results of a prospective study. Z Orthop Unfall. 2023;161:260-270. Go to original source... Go to PubMed...
  14. Hwang BH, Yoon JY, Nam CH, Jung KA, Lee SC, Han CD, Moon SH. Fungal peri-prosthetic joint infection after primary total knee replacement. J Bone Joint Surg Br. 2012;94:656-659. Go to original source... Go to PubMed...
  15. Izakovicova P, Borens O, Trampuz A. Periprosthetic joint infection: current concepts and outlook. EFORT Open Rev. 2019;4:482-494. Go to original source... Go to PubMed...
  16. Ji B, Zhang X, Xu B, Guo W, Mu W, Cao L. Single-stage revision for chronic fungal periprosthetic joint infection: an average of 5 years of follow-up. J Arthroplasty. 2017;32:2523-2530. Go to original source... Go to PubMed...
  17. Kong, E.F.; Tsui, C.; Kucharíková, S.; Andes, D.; Van Dijck, P.; Jabra-Rizk, M.A. Commensal protection of Staphylococcus aureus against antimicrobials by Candida albicans biofilm matrix. mBio. 2016;7:e01365-16. Go to original source... Go to PubMed...
  18. Kuo FC, Goswami K, Shohat N, Blevins K, Rondon AJ, Parvizi J. Two-stage exchange arthroplasty is a favorable treatment option upon diagnosis of a fungal periprosthetic joint infection. J Arthroplasty. 2018;33:3555-3560. Go to original source... Go to PubMed...
  19. Lee YR, Kim HJ, Lee EJ, Sohn JW, Kim MJ, Yoon YK. Prosthetic joint infections caused by Candida species: a systematic review and a case series. Mycopathologia. 2019;184:23-33. Go to original source... Go to PubMed...
  20. Miller RB, McLaren AC, Clarke HD, McLemore R. Voriconazole is delivered from antifungal-loaded bone cement. Clin Orthop Relat Res. 2013;471:195-200. Go to original source... Go to PubMed...
  21. Nace J, Siddiqi A, Talmo CT, Chen AF. Diagnosis and management of fungal periprosthetic joint infections. J Am Acad Orthop Surg. 2019;27:804-818. Go to original source... Go to PubMed...
  22. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62:1-50. Go to original source... Go to PubMed...
  23. Parvizi J, Gehrke T, Chen AF. Proceedings of the International Consensus on Periprosthetic Joint Infection. Bone Joint J. 2013;95-B:1450-1452. Go to original source... Go to PubMed...
  24. Richardson MD. Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother. 2005;56(Suppl 1):5-11. Go to original source... Go to PubMed...
  25. Schoof B, Jakobs O, Schmidl S, Klatte TO, Frommelt L, Gehrke T, Gebauer M. Fungal periprosthetic joint infection of the hip: a systematic review. Orthop Rev (Pavia). 2015;7:5748. Go to original source... Go to PubMed...
  26. Sealy PI, Nguyen C, Tucci M, Benghuzzi H, Cleary JD. Delivery of antifungal agents using bioactive and nonbioactive bone cements. Ann Pharmacother. 2009;43:1606-1615. Go to original source... Go to PubMed...
  27. Stratov I, Korman TM, Johnson PDR. Management of Aspergillus osteomyelitis: report of failure of liposomal amphotericin B and response to voriconazole in an immunocompetent host and literature review. Eur J Clin Microbiol Infect Dis. 2003;22:277-283. Go to original source... Go to PubMed...
  28. Ueng SW, Lee CY, Hu C, Hsieh PH, Chang Y. What is the success of treatment of hip and knee candidal periprosthetic joint infection? Clin Orthop Relat Res. 2013;471:3002-3009. Go to original source... Go to PubMed...